164 related articles for article (PubMed ID: 7529211)
1. The expression profile of alternatively spliced neuronal c-src RNA distinguishes between human tumours of the sympatho-adrenal lineage.
Ortoft E; Bjelfman C; Hedborg F; Grimelius L; Påhlman S
Int J Cancer; 1995 Jan; 60(1):38-44. PubMed ID: 7529211
[TBL] [Abstract][Full Text] [Related]
2. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B
Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310
[TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours.
Nilsson O; Wängberg B; Kölby L; Schultz GS; Ahlman H
Int J Cancer; 1995 Mar; 60(5):645-51. PubMed ID: 7860139
[TBL] [Abstract][Full Text] [Related]
4. Expression of alternatively spliced src messenger RNAs related to neuronal differentiation in human neuroblastomas.
Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Takahashi H; Simizu B
Cancer Res; 1993 Jul; 53(13):3179-85. PubMed ID: 8319227
[TBL] [Abstract][Full Text] [Related]
5. Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas.
Lee JP; Hung YP; O'Dorisio TM; Howe JR; Hornick JL; Bellizzi AM
Histopathology; 2017 Oct; 71(4):503-510. PubMed ID: 28464318
[TBL] [Abstract][Full Text] [Related]
6. Expression of the neuronal form of pp60c-src in neuroblastoma in relation to clinical stage and prognosis.
Bjelfman C; Hedborg F; Johansson I; Nordenskjöld M; Påhlman S
Cancer Res; 1990 Nov; 50(21):6908-14. PubMed ID: 1698545
[TBL] [Abstract][Full Text] [Related]
7. Analysis of cDNAs of the proto-oncogene c-src: heterogeneity in 5' exons and possible mechanism for the genesis of the 3' end of v-src.
Dorai T; Levy JB; Kang L; Brugge JS; Wang LH
Mol Cell Biol; 1991 Aug; 11(8):4165-76. PubMed ID: 1712905
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Mutations and Expressions of
Islam F; Pillai S; Gopalan V; Lam AK
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33114456
[TBL] [Abstract][Full Text] [Related]
9. The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).
Kaltsas GA; Papadogias D; Grossman AB
Front Horm Res; 2004; 31():61-75. PubMed ID: 14674305
[No Abstract] [Full Text] [Related]
10. RET proto-oncogene point mutations in sporadic neuroendocrine tumors.
Komminoth P; Roth J; Muletta-Feurer S; Saremaslani P; Seelentag WK; Heitz PU
J Clin Endocrinol Metab; 1996 Jun; 81(6):2041-6. PubMed ID: 8964826
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel neuronal C-SRC exon expressed in human brain.
Pyper JM; Bolen JB
Mol Cell Biol; 1990 May; 10(5):2035-40. PubMed ID: 1691439
[TBL] [Abstract][Full Text] [Related]
12. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
[TBL] [Abstract][Full Text] [Related]
13. Developmental gene expression of sympathetic nervous system tumors reflects their histogenesis.
Hoehner JC; Hedborg F; Eriksson L; Sandstedt B; Grimelius L; Olsen L; Påhlman S
Lab Invest; 1998 Jan; 78(1):29-45. PubMed ID: 9461120
[TBL] [Abstract][Full Text] [Related]
14. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas.
Lam KY; Lo CY; Wat NM; Luk JM; Lam KS
J Clin Pathol; 2001 Jun; 54(6):443-8. PubMed ID: 11376017
[TBL] [Abstract][Full Text] [Related]
16. PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma-paraganglioma origin.
Remes SM; Leijon H; Vesterinen T; Louhimo J; Pulkkinen V; Ezer S; Kere J; Haglund C; Arola J
APMIS; 2020 Nov; 128(11):563-572. PubMed ID: 32794589
[TBL] [Abstract][Full Text] [Related]
17. A comparative immunohistochemical study of phaeochromocytomas and paragangliomas.
Fraga M; García-Caballero T; Antúnez J; Couce M; Beiras A; Forteza J
Histol Histopathol; 1993 Jul; 8(3):429-36. PubMed ID: 8358154
[TBL] [Abstract][Full Text] [Related]
18. Long intergenic noncoding RNA profiles of pheochromocytoma and paraganglioma: A novel prognostic biomarker.
Ghosal S; Das S; Pang Y; Gonzales MK; Huynh TT; Yang Y; Taieb D; Crona J; Shankavaram UT; Pacak K
Int J Cancer; 2020 Apr; 146(8):2326-2335. PubMed ID: 31469413
[TBL] [Abstract][Full Text] [Related]
19. Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy.
Guo Z; Lloyd RV
Adv Anat Pathol; 2015 Sep; 22(5):283-93. PubMed ID: 26262510
[TBL] [Abstract][Full Text] [Related]
20. High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type.
Van Limpt VA; Chan AJ; Van Sluis PG; Caron HN; Van Noesel CJ; Versteeg R
Int J Cancer; 2003 May; 105(1):61-9. PubMed ID: 12672031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
